Boston Scientific Files 8-K with Corporate Updates

Ticker: BSX · Form: 8-K · Filed: 2024-05-06T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, filing-update, bylaws

Related Tickers: BSX

TL;DR

BSX filed an 8-K on May 6th for events on May 2nd - corporate docs, shareholder votes, and financials.

AI Summary

Boston Scientific Corporation filed an 8-K on May 6, 2024, reporting events that occurred on May 2, 2024. The filing indicates changes to the company's articles of incorporation or bylaws, submission of matters to a vote of security holders, and includes financial statements and exhibits. Specific details on these events, including any material financial impacts or voting outcomes, are not elaborated in this summary.

Why It Matters

This filing signals potential changes in Boston Scientific's corporate governance or structure, which could impact shareholder rights or future business operations.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain immediate negative news or significant financial events.

Key Players & Entities

FAQ

What specific amendments were made to Boston Scientific's articles of incorporation or bylaws?

The filing indicates that amendments to articles of incorporation or bylaws were submitted, but the specific details of these amendments are not provided in the summary information.

What matters were submitted to a vote of security holders?

The filing states that matters were submitted to a vote of security holders, but the nature of these matters is not specified in the provided text.

What are the key financial statements and exhibits included in this filing?

The filing mentions the submission of financial statements and exhibits, but the content or specific nature of these documents is not detailed.

When did the events reported in this 8-K filing occur?

The earliest event reported in this 8-K filing occurred on May 2, 2024.

What is Boston Scientific Corporation's fiscal year end?

Boston Scientific Corporation's fiscal year end is December 31 (1231).

From the Filing

0000885725-24-000048.txt : 20240506 0000885725-24-000048.hdr.sgml : 20240506 20240506161343 ACCESSION NUMBER: 0000885725-24-000048 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240502 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240506 DATE AS OF CHANGE: 20240506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 24917636 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 8-K 1 bsx-20240502.htm 8-K bsx-20240502 0000885725 12/31 false 0000885725 2024-05-02 2024-05-02 0000885725 us-gaap:CommonStockMember 2024-05-02 2024-05-02 0000885725 bsx:SeniorNotedue2027Member 2024-05-02 2024-05-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 _____________________________________________________________________ Date of Report (Date of earliest event reported): May 2, 2024 BOSTON SCIENTIFIC CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-11083 04-2695240 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)      300 Boston Scientific Way , Marlborough , Massachusetts                  01752-1234     (Address of principal executive offices)                           (Zip Code) ( 508 ) 683-4000 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.01 par value per share BSX New York Stock Exchange 0.625% Senior Notes due 2027 BSX27 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company    ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐ Item 5.03    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. In February 2024, the Board of Directors (the “Board&#8

View on Read The Filing